Seeking Alpha

Peregrine Pharma EPS in-line , misses on revenue

  • Peregrine Pharma (PPHM): FQ1 EPS of -$0.05 in-line.
  • Revenue of $4.68M misses by $0.07M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)